文献速递慢病防控与筛查

无传统风险因素人群肝细胞癌风险评分开发与验证

Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score.
PubMed 文献 · Int J Epidemiol · 2020-01-01

多变量Cox回归识别出年龄、性别、吸烟、糖尿病、总胆固醇和血清谷丙转氨酶6个独立风险因素,构建19分制评分,10年HCC风险范围0.0%至6.16%。推导与验证队列10年AUROC分别为0.83(95%CI:0.77,0.88)和0.92(95%CI:0.89,0.95)。

要点

  • 无传统风险因素者仍可发生HCC,需针对性风险评估工具。
  • 新评分基于6项常规指标,简单易用,区分度良好。
  • 评分可用于识别高风险个体以指导风险降低干预。

核心结论

  • 开发并验证了一种简单易用的HCC风险评分,用于预测无传统风险因素个体的HCC发生风险。

主要发现

  • 多变量Cox回归分析识别出六个独立风险因素:年龄、性别、吸烟、糖尿病、总胆固醇水平和血清谷丙转氨酶水平。
  • 构建了19分制HCC风险评分,最低和最高评分的10年HCC风险分别为0.0%和6.16%。
  • 推导队列10年预测HCC发生的AUROC为0.83(95%CI:0.77,0.88),验证队列为0.92(95%CI:0.89,0.95)。
  • 预测风险与Kaplan-Meier观察到的HCC风险相关性良好。

临床怎么用

  • 该评分可用于无传统风险因素人群的HCC风险评估,辅助临床管理决策,包括风险降低干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although hepatocellular carcinoma (HCC) occurs mostly in patients with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection or heavy alcohol use or cirrhosis, some patients develop HCC without these risk factors. Our objective in this study was to develop and validate a new HCC risk score that could stratify HCC risk in patients who develop HCC without known risk factors. METHODS: A new HCC risk score was developed using a nationwide, population-based cohort among individuals without chronic HBV infection, chronic HCV infection, heavy alcohol use or cirrhosis (n = 467 206, derivation cohort). The performance of the HCC risk score was validated using an independent Samsung Medical Center Health Promotion Center cohort (n = 91 357, validation cohort). RESULTS: Multivariable Cox regression analysis identified six independent risk factors: age, sex, smoking, diabetes, total cholesterol level and serum alanine aminotransferase level. A 19-point scale for HCC risk score was developed, with 10-year risk of HCC ranging from 0.0% to 6.16% for the lowest and highest risk scores, respectively. The area under the receiver operating characteristics curve values (AUROCs) to predict HCC development were 0.83 [95% confidence interval (CI): 0.77, 0.88)] and 0.92 (95% CI: 0.89, 0.95) at 10 years in the derivation and validation cohorts, respectively. Predicted risk was well correlated with the Kaplan-Meier observed HCC risk. CONCLUSIONS: A simple-to-use, novel HCC risk score was developed for predicting HCC development in individuals without alleged risk factors. It can be used to assess the risk of HCC in this population so that decisions about their clinical management, including risk reduction interventions, can be subsequently made.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Sinn DH, Kang D, Cho SJ, et al. Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score. Int J Epidemiol. 2020. PMID: 32725117. doi:10.1093/ije/dyaa089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。